Albinism: Clinical Trials

3 trials for Albinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1
Phase 31Terminated 1

Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vision Response to Dopamine Replacement
Levodopa/carbidopa - Albinism, Oculocutaneous Albinism
Phase 2TerminatedUniversity of Wisconsin, Madison202012-10-172019-06-11
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis
Phase 1 / Phase 2TerminatedNational Human Genome Research Institute (NHGRI)32007-04-012013-08-02
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
Stem Cell Transplant, Myeloablative conditioning regimen - Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders
Phase 2 / Phase 3TerminatedMasonic Cancer Center, University of Minnesota222000-09-012018-01-23

Narrower conditions

Albinism, Oculocutaneous (2)  ·  Chediak-Higashi Syndrome (1)  ·  Hematologic Diseases (1)  ·  Hermanski-Pudlak Syndrome (1)  ·  Histiocytosis, Langerhans-Cell (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lymphohistiocytosis, Hemophagocytic (1)  ·  Lymphoproliferative Disorders (1)  ·  Metabolic Diseases (1)  ·  Platelet Storage Pool Deficiency (1)  ·  Pulmonary Fibrosis (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Eye Diseases (3)  ·  Eye Diseases, Hereditary (3)  ·  Genetic Diseases, Inborn (3)  ·  Amino Acid Metabolism, Inborn Errors (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hypopigmentation (2)  ·  Lung Diseases, Interstitial (2)  ·  Metabolism, Inborn Errors (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pigmentation Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Acetylcysteine (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Erythromycin (1)  ·  Losartan (1)  ·  Pravastatin (1)  ·  Stem Cell Transplantation (1)  ·  carbidopa, levodopa drug combination (1)  ·  zileuton (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (3)

Top investigators

Angela Smith, MD (1)  ·  Michael C Struck, MD (1)  ·  Thomas Markello, M.D. (1)